Engineered via sandwich multi-layer embedding, ensuring biocompatible color encapsulation and optical clarity under CE, ISO, and SGS standards.
With 6+ years of global export discipline, Shenzhen Eyesharelenses Co., Ltd. integrates advanced micro-encapsulation technology with cleanroom automation to safeguard clinical ocular integrity.
Our manufacturing framework is fully audited onsite by the SGS Group. We adhere strictly to ISO 13485 medical device quality systems, ensuring every production batch provides full traceability from raw monomer synthesis to sterile vial capping.
To protect the corneal epithelium, our patented pigment isolation printing process embeds micro-colorants securely between double hydrogel substrate layers, guaranteeing zero pigment contact with ocular tissue while preserving maximum Dk/t oxygen flow.
We provide end-to-end industrial private label incubation. From bespoke iris pattern rendering and custom base curve casting to MHRA/FDA compliant bilingual blister packaging, our low MOQ infrastructure scales effortlessly with emerging optical brands.
Strategic insights into polymer advancements, precision optical molding, and the clinical evolution shaping modern therapeutic and cosmetic lenses.
Traditional p-HEMA (poly-2-hydroxyethyl methacrylate) materials have provided exceptional wettability and tactile softness. However, the international market is accelerating toward Silicone-Hydrogel formulations that boost oxygen transmissibility (Dk/t) far beyond 80 units. This technological shift virtually eliminates corneal hypoxia, extending safe continuous wear times from 8 to 14+ hours without desiccation.
Legacy color stamping utilized rudimentary dot-matrix printing, resulting in visible pixelation and unnatural limbal rings. Modern OEM suppliers utilize nano-pigment laser jet dispersing. This achieves sub-micron dot dispersion mimicking real human stromal fibers, giving dark eyes natural transitions without impairing the peripheral field of view.
Ocular wellness criteria now mandate functional radiation defense. Modern formulations embed Class 1/Class 2 UV-blocking monomers directly into the polymeric matrix, absorbing over 90% of UVA and 99% of UVB rays. Concurrently, emerging iterations incorporate high-energy visible (HEV) blue-light filtering to reduce digital asthenopia across computer and smartphone users.
Navigating changing compliance protocols, SKU rationalization, and agile logistics across European, North American, and Asian import corridors.
Procurement for peak retail periods—especially Halloween and cosplay conventions—requires precise scheduling. B2B buyers must finalize formulation validation and sample runs by late June, booking bulk shipments before mid-August to absorb maritime delays and customs clearance.
With the EU Medical Device Regulation (MDR 2017/745) and UK MHRA frameworks fully enforcing zero-power cosmetic lenses as Class IIa/IIb medical devices, buyers must audit manufacturer technical documentation, including biocompatibility Cytotoxicity (ISO 10993-5) and Stability profiles.
E-commerce private label models demand flexibility. Modern procurement favors vendors offering tiered production models—starting from 10–20 pairs for rapid inventory turnover and scaling to 50,000 units with unified brand serialization and barcodes.
Environmental regulations across Western Europe are driving procurement teams to phase out excessive blister plastics. Forward-thinking brands are switching to post-consumer recycled paper cartons, soy-based non-toxic inks, and polypropylene blister cups engineered for minimal landfill footprint.
Comprehensive compliance, technical parameters, and ordering guidelines answered by our engineering and regulatory affairs team.